Case Report October 31, 2019

Bethanechol as a Corrective for Urinary Retention Associated With Olanzapine Administration

; ;

Prim Care Companion CNS Disord 2019;21(5):19l02429

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Bethanechol, a long-acting muscarinic agonist, has been successfully used as a corrective for bowel dysmotility associated with clozapine. Although bethanechol is indicated as a treatment for urinary retention, several reports in the literature have questioned its effectiveness. We report a case in which bethanechol clearly improved urinary retention as an adverse effect of olanzapine.